{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2019"],"data_sharing_plan":["IPD Sharing (as of July 2023): Undecided"],"condition":["Ovarian Cancer","Squamous Cell Carcinoma of Head and Neck","Carcinoma","Head and Neck Squamous Cell Carcinoma","Colorectal Cancer","Non-small Cell Lung Cancer","Prostate Cancer","Urothelial Carcinoma","Breast Cancer"],"disease":["Ovarian Cancer","Squamous Cell Carcinoma Of Head And Neck","Carcinoma","Non-small Cell Lung Cancer","Colorectal Cancer","Urothelial Carcinoma","Prostate Cancer","Head And Neck Squamous Cell Carcinoma","Breast Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2289098"],"location":["United States"],"study_start_month":["8"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer","description":"This study is to evaluate diagnostic performance, safety and timing of post-dose imaging of ONM-100, an intraoperative fluorescence imaging agent for the detection of cancer in patients with solid tumors undergoing routine surgery.","dates":{"creation":"2019-08-15"},"accession":"2289098","cross_references":{"ClinicalTrials___gov":["NCT03735680"]}}